Serum levels of ciprofloxacin after single oral doses in patients with septicemia M. D'EspineF. BellidoB. Hirschel Article Pages: 1019 - 1023
Evaluation of pefloxacin, ofloxacin and ciprofloxacin in the treatment of thirty-nine cases of chronic osteomyelitis P. DellamonicaE. BernardH. B. Drugeon Article Pages: 1024 - 1030
Antibody specificity for human immunodeficiency virus type 1 in serum and cerebrospinal fluid from patients with AIDS and AIDS-related complex P. B. WilloughbyJ. S. MidgettJ. D. Folds Article Pages: 1031 - 1037
Failure of mupirocin-resistant staphylococci to inactivate mupirocin B. Cookson Notes Pages: 1038 - 1040
Single-dose ciprofloxacin in the treatment of uncomplicated urinary tract infection in women R. RazE. RottensterichI. Potasman Notes Pages: 1040 - 1042
9-(2-phosphonylmethoxyethyl)-2,6-diaminopurine (PMEDAP): A novel agent with anti-human immunodeficiency virus activity in vitro and potent anti-moloney murine sarcoma virus activity in vivo L. NaesensJ. BalzariniE. De Clercq New Antimicrobial Agents Pages: 1043 - 1047
Antibacterial and plasmid curing activity of lomefloxacin in vitro E. DerlotC. Poyart-SalmeronP. Courvalin New Antimicrobial Agents Pages: 1048 - 1052
Antibacterial activity of the new carbapenem meropenem (SM-7338) against clinical isolates G. RavizzolaG. PinsiA. Turano New Antimicrobial Agents Pages: 1053 - 1061
Comparative in vitro antibacterial activity of the new carbapenem meropenem (SM-7338) M. R. VisserI. M. HoepelmanJ. Verhoef New Antimicrobial Agents Pages: 1061 - 1064
Susceptibility of anaerobic bacteria to the new streptogramin RP 59500 in vitro C. E. NordA. LindmarkI. Persson New Antimicrobial Agents Pages: 1064 - 1067
Effects of cilofungin (LY121019) on carbohydrate and sterol composition ofCandida albicans M. PfallerJ. RileyT. Koerner New Antimicrobial Agents Pages: 1067 - 1070
Value of new quinolones in the treatment and prophylaxis of infectious diseases: Introductory remarks J. S. WolfsonB. E. Murray Current Topic: Introduction Pages: 1071 - 1074
Clinical role of the quinolones today and in the future F. A. Waldvogel Current Topic: Editorial Pages: 1075 - 1079
Quinolone antimicrobial agents: Adverse effects and bacterial resistance J. S. Wolfson Current Topic: Review Pages: 1080 - 1092
Clinical utility of new quinolones in treatment of osteomyelitis and lower respiratory tract infections A. S. Bayer Current Topic: Review Pages: 1102 - 1110
Quinolone antibacterial agents for the treatment of genitourinary tract infections T. J. BabinchakR. J. Fass Current Topic: Review Pages: 1111 - 1116
Increasing incidence ofCorynebacterium group D2 strains resistant to norfloxacin and ciprofloxacin F. SorianoR. Fernández-RoblasM. Romero Letters To The Editor Pages: 1117 - 1118
Double infections with human immunodeficiency virus types 1 and 2 in Spanish subjects M. Teresa GorriñoM. Mar MateosR. Cisterna Letters To The Editor Pages: 1118 - 1119